TreeFrog Therapeutics

Cell & Gene Therapy · Regenerative Medicine
Sponsors visas

Facts

as of Nov 20, 2026

TreeFrog Therapeutics develops transformative regenerative medicine at industrial scale, enabling cell therapies to treat millions of patients worldwide.

Official records
Wikidata Q107542714

These are the key facts about TreeFrog Therapeutics on Alion as of Nov 20, 2026. The latest round is Venture - Series Unknown of $32.4M, announced in 2025.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Named in the work visa registers of United States.

United StatesUS 1 #10,291 of 16,738 sponsors
1H-1B filings in 12 months
$93kMedian offered salary
0Open roles in United States
Who they sponsor
Other biological scientists1
The salary offered for each occupationVisa pass · 90 credits

In the register as TreeFrog Therapeutics Inc., Cambridge, MA

Other sponsors in the same field
Alert me
US Department of Labor · latest filing Jun 16, 2026 · the register ↗

Financials

Funding rounds, investors and revenue on record.

$32.4MTotal raised
Venture - Series UnknownLatest round
1Rounds and grants
Money by yearUSD, rounds and grants
2025$32.4M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Money

TreeFrog Therapeutics has $32.4M paid in by investors, lenders and donors.

$32.4MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Equity raised
May 2025 · Venture round
$32.4MPaid
Taxes
No public tax figures for this company or its entities.
People cost

TreeFrog Therapeutics filed a median H-1B wage of $92k in 2026.

$92kMedian H-1B wage, 20261 casesSource ↗
Median H-1B wage by role, 2026scale to $92k
Senior Research Associate · 1$92k
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

Milestones

Each milestone is dated by its source: registers, filings, the press